クラミジア性子宮頸管炎に対する経口キノロン薬balofloxacinの臨床的検討

• 斉藤 十一

  順天堂大学医学部産婦人科学教室

• 深間内 一孝

  順天堂大学医学部産婦人科学教室

• 桑原 慶紀

  順天堂大学医学部産婦人科学教室

書誌事項

タイトル別名

• Clinical efficacy of balofloxacin, a newly oral quinolone, against chlamydial cervicitis

抄録

Clinical studies were carried out on balofloxacin (BLFX), a new fluoroquinolone antibiotic, against chlamydial infections in patients with cervicitis.<BR>BLFX was administered oraly 200 or 400mg (b. i. d.) for 7-10 days. Two patients with equivocal evidence of chlamydial infection were excluded. Chlamydia trachomatis DNA or antigen disappeared in 8 cases after the treatment, and the bacteriological response was evaluated as eradicated in 8 cases. With reference to the clinical response, the symptoms of infection improved or disappeared in these cases, and the efficacy rate was therefore evaluated as 100%. No adverse reactions or abnormalities in laboratory findings due to the treatment were recognized.

収録刊行物

• 日本化学療法学会雑誌

  日本化学療法学会雑誌 43 (Supplement5), 627-629, 1995

  公益社団法人 日本化学療法学会

キーワード

• 産婦人科領域感染症

詳細情報

• CRID: 1390001206288585344
• NII論文ID: 10005469264
• NII書誌ID: AN10472127
• DOI: 10.11250/chemotherapy1995.43.supplement5_627
• ISSN: 18845886
• ISSN: 13407007
• Web Site: https://search.jamas.or.jp/link/ui/1996090255
• 本文言語コード: ja
• データソース種別:
  • JaLC
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可